HealthEquity Director Gayle Wellborn Receives 2,877 Restricted Stock Units

This SEC Form 4 filing reports that Gayle Wellborn Furgurson, a director of HealthEquity, Inc. (HQY), received 2,877 restricted stock units (RSUs) on June 25, 2026. The RSUs were granted at $0 per share and represent a contingent right to receive one share of common stock each. Following this transaction, Wellborn's total holdings increased to 22,610 shares. The RSUs will vest in full on the earlier of June 25, 2027, or the date of the company's next annual stockholder meeting in June 2027. Vested shares will be delivered to Wellborn upon vesting. The filing was signed by Michael Newton as Attorney-in-Fact, referencing a previously filed Power of Attorney from June 2023. This transaction represents equity compensation to a company director as part of standard director compensation arrangements.